Microbiotica, Genentech in microbiome deal

Genentech Inc. partnered with Microbiotica Ltd. (Cambridge, U.K.) to discover targets and therapeutics for inflammatory bowel disease (IBD) using Microbiotica’s precision metagenomics

Read the full 227 word article

User Sign In